Header Logo

Connection

LAISING YEN to Cystadenocarcinoma, Serous

Back to Details
This is a "connection" page, showing publications LAISING YEN has written about Cystadenocarcinoma, Serous.
LAISING YEN
Connection Strength
0.431
Cystadenocarcinoma, Serous
  1. Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma. Proc Natl Acad Sci U S A. 2015 Mar 17; 112(11):E1272-7.
    View in: PubMed
    Score: 0.431
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.